CLINICAL_TRIALS ClinicalTrials.gov record update

Phase I Study of Anti-GD2 Chimeric Antigen Receptor-Expressing T Cells in Pediatric and Young Adult Patients Affected by Relapsed/Refractory Central Nervous System Tumors

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Record identity and dates

Source: ClinicalTrials.gov
Source record ID: NCT05298995
Title field or adapter rule: protocolSection.identificationModule.officialTitle
Ingested At: 2026-04-25T22:26:53.967329+00:00
Published At: 2025-02-05T00:00:00+00:00
Record Updated At: 2025-02-05
Timestamp Basis: source retrieval time was not retained by the feed adapter
Date limitation: source retrieval time was not retained by the feed adapter

protocolSection.conditionsModule.conditions: ["Brain Tumor, Pediatric", "Medulloblastoma, Childhood", "Embryonal Tumor", "High Grade Glioma", "Diffuse Midline Glioma", "Diffuse Intrinsic Pontine Glioma", "Brain Tumor Adult"]
protocolSection.statusModule.lastUpdatePostDateStruct.date: "2025-02-05"
protocolSection.identificationModule.nctId: "NCT05298995"
protocolSection.identificationModule.officialTitle: "Phase I Study of Anti-GD2 Chimeric Antigen Receptor-Expressing T Cells in Pediatric and Young Adult Patients Affected by Relapsed/Refractory Central Nervous System Tumors"
protocolSection.statusModule.overallStatus: "RECRUITING"
protocolSection.designModule.phases: ["PHASE1"]
protocolSection.statusModule.resultsFirstPostDateStruct.date: ""

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.